EMPOWER YOUR NEXT ONCOLOGY STUDY
Preclinical Oncology Discovery Services
With more than 6,000 studies completed, we have amassed extensive experience and deep insights to inform end-to-end preclinical oncology research. Discover our open capacities in quick turn studies to expedite development of your next potentially life-saving compound.
More than 400 robust preclinical oncology pharmacology models
Access hundreds of cell line assays and tumor models, plus thousands of potential patients in our oncology discovery services
Leverage open capacity in studies for standard efficacy/MTD – ARB and GRN, radiolabeled therapies, SARRP, BLI, cell therapy, FastTrack, ABSL2 – ARB and GRN
When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to move life-changing drug candidates through non-GLP, preclinical development and oncology clinical trials quickly and efficiently.
We've helped hundreds of companies discover their next life-improving compound.
Immunotherapy & Adoptive Cell Therapy Support
We offer over 30 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research. We are continually improving and expanding adoptive cell therapy capabilities:
PRECLINICAL ONCOLOGY RENOVATION
Fully invested in your fight against cancer from the very beginning
The fight against cancer starts in the lab. That’s why we’ve invested in a renovation that doubled the size of our preclinical oncology facility in Ann Arbor, Michigan. Here you can discover enhanced capabilities and greater capacity to speed up your preclinical oncology programs.
Drive your oncology research forward
In the fight against cancer, every second matters. Enroll today for a quick study start, while slots are still available. Our staff is standing by to help you begin oncology discovery services that get your study up and running fast.Schedule Your Study Today